So far, antibodies against thrombin, PC, plasmin, and FXa have been detected in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), allowing researchers to characterize their role in the underlying pathways that lead to disease onset [15]. Here, PLG is linked to systemic lupus erythematosus.